Loading...

COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

New

Neurology devices Market by Product (Neurostimulation Devices, Neurosurgery Device, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, and Others) and End User (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics): Global Opportunity Analysis and Industry Forecast, 2019–2026

A05956
Pages: 182
Jan 2020 | 1465 Views
 
Author(s) : Kavita Joshi , Onkar Sumant
Tables: 85
Charts: 05
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurology Devices Market

Request Now !

The global Neurology Devices Market was valued at $9,242 million in 2018, and is expected to reach $ 17,410 million by 2026, registering a CAGR of 8.1% from 2019 to 2026. Neurology is a branch of science that deals with the disorders of the nervous system, which majorly comprise the brain, blood vessels, muscles and nerves. The neurovascular devices such as cerebrospinal fluid management devices, interventional devices, and others used for the treatment of neurological disorders such as Alzheimer’s, tumors, and Parkinson’s disease. Moreover, cerebrospinal fluid management devices include shunts, valves, and external drainage systems to maintain the flow of cerebrospinal fluid and drain excess fluid out from the brain. Furthermore, a shunt offers an alternative fluid pathway through which the cerebrospinal fluid sidesteps the obstructions in the fluid compartments of the brain, and acts when the fluid absorption is otherwise reduced. The bypass created with the help of the stent relieves the excess fluid buildup that is responsible for hydrocephalus. Moreover, various other devices or instruments are available in the market, which are used for the treatment of neurological devices such as catheters, stents, ultrasonic aspirators, and stereotactic systems.

Neurological devices market 2019-2026

Get more information on this report : Request Sample Pages

The major factors driving the global neurology devices market growth include rise in geriatric population across the globe, high demand for minimally invasive surgeries, rise in disposable income, improvement in healthcare infrastructure, and development of advanced devices. In addition, significant increase in the prevalence of neurological disorders across the globe propels the market growth. For instance, as per the estimates of the Centers for Disease Control and Prevention, more than 795,000 people in the U.S. suffer from stroke every year. In addition, rise in geriatric population poses risk for increase in incidence of neurovascular disorders (such as stroke). For instance, according to the Internet Stroke Center, o an average, nearly 75% of people aged over 65 years are reported to suffer from stroke every year. Moreover, the risk of having a stroke doubles after the age of 55, which propels the adoption of neurology devices, thereby supplementing the market growth. However, implementation of stringent government regulations toward the approval of neurology devices and dearth of skilled neurosurgeons are the key factors anticipated to hamper the market growth. On the contrary, the introduction of new products and technological advancements in the neurology devices to make disease diagnosis easier have aided in the efficient treatment of neurovascular disorders, which is expected to provide lucrative opportunities for market expansion during the forecast period.

Neurology devices Market
By Application

Your browser does not support the canvas element.

Neurosurgery Devices segment is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

GLOBAL NEUROLOGY DEVICES MARKET SEGMENTATION

The global neurology devices market is segmented into product, end user, and region. By product, the market is segregated into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid management devices, and others. On the basis of end user, it is classified into hospitals, neurology clinics, and ambulatory care centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Neurology devices Market
By Technology

Your browser does not support the canvas element.

Mass spectrometry is projected as one of the most lucrative segments.

Get more information on this report : Request Sample Pages

Product segment review

By product, the cerebrospinal fluid management devices segment dominated the neurology devices Market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to surge in usage of these devices for diagnosis of various neurological devices. For instance, these management devices are widely being used for the diagnosis and treatment of multiple sclerosis, myelitis, encephalitis, and others.

Neurology devices Market
By Region

2026
North America 
Europe
Asia-pacific
Lamea

LAMEA region would exhibit the highest CAGR of 10.0% during 2019-2026.

Get more information on this report : Request Sample Pages

End user segment review

By end user, the hospital segment garnered maximum share in 2018, and is anticipated to continue this during the forecast period. This is attributed to the easy availability of neurological devices in hospital settings and preference among patients to visit hospitals for diagnosis and treatment of neurological devices.

Region segment review

North America held the largest share in the neurology devices market in 2018, followed by Europe. The factors that drive the overall growth of the North American neurology devices market include increase in government funds for R&D of novel neurological devices and surge in prevalence of neurological diseases such as Alzheimer’s and Parkinson’s disease. Furthermore, easy availability of advanced neurological devices coupled with well-developed healthcare infrastructure and presence of leading players significantly contribute toward the market growth. However, LAMEA is anticipated to grow at the highest rate during the analysis period, owing to increase in incidence of neurological diseases and presence of large patient pool in this region. In addition, the major factors driving the growth of the neurology devices market in the region include increase in per capita income in many countries, rise in government initiatives for improvement of the healthcare sector, and surge in focus of leading manufacturers on expanding their geographic presence in emerging countries to capture maximum share of the neurology devices market.

Comprehensive competitive analysis and profiles of major market players such as Abbott Laboratories., B. Braun Melsungen AG, Boston Scientific Corporation., Integra LifeSciences Holdings Corporation, LivaNova PLC, Johnson & Johnson, Medtronic Plc., Magstim Co Ltd., Penumbra, Inc., and Stryker Corporation are provided in this report.

Key Benefits for Stakeholders

  • The neurology devices market share and analysis is based on a comprehensive analysis of key developments in the industry.
  • The development strategies adopted by key market players are enlisted to understand the competitive scenario of the global market.
  • The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
  • The global neurology devices market trends are studied from 2018 to 2026.
  • Information about key drivers, restrains, and opportunities and their impact analysis on the market size is provided.
  • Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
  • The quantitative analysis of the global neurology devices market from 2019 to 2026 is provided to determine the market potential.

Key Market Segments

By Product

  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid Devices
  • Others

By End-User

  • Hospitals
  • Neurology Clinics
  • Ambulatory Care Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Research methodology

1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry

3.4. Top player positioning
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Surge in neurological disorders
3.5.1.2. Rising demand for noninvasive diagnostic techniques for neurological disorders

3.5.2. Restraint

3.5.2.1. Implementation of stringent government regulations towards approval of neurology devices

3.5.3. Opportunity

3.5.3.1. Various growth opportunities in emerging economies

CHAPTER 4: NEUROLOGY DEVICES MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market size and forecast

4.2. Neurostimulation devices

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country

4.3. Neurosurgery device

4.3.1. Key market trends and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country

4.4. Interventional neurology devices

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country

4.5. Cerebrospinal fluid management devices

4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.5.3. Market share analysis, by country

4.6. Others

4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast
4.6.3. Market share analysis, by country

CHAPTER 5: NEUROLOGY DEVICES MARKET, BY END USER

5.1. Overview

5.1.1. Market size and forecast

5.2. Hospitals

5.2.1. Market size and forecast
5.2.2. Market share analysis, by country

5.3. Ambulatory surgery centers

5.3.1. Market size and forecast
5.3.2. Market share analysis, by country

5.4. Neurology clinics

5.4.1. Market size and forecast
5.4.2. Market share analysis, by country

CHAPTER 6: NEUROLOGY DEVICES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast, by country
6.2.3. Market size and forecast, by product
6.2.4. Market size and forecast, by end user

6.2.4.1. U.S. market size and forecast, by product
6.2.4.2. U.S. market size and forecast, by end user
6.2.4.3. Canada market size and forecast, by product
6.2.4.4. Canada market size and forecast, by end user
6.2.4.5. Mexico market size and forecast, by product
6.2.4.6. Mexico market size and forecast, by end user

6.3. Europe

6.3.1. Key growth factors and opportunities
6.3.2. Market size and forecast, by country
6.3.3. Market size and forecast, by product
6.3.4. Market size and forecast, by product

6.3.4.1. Germany market size and forecast, by product
6.3.4.2. Germany market size and forecast, by end user
6.3.4.3. France market size and forecast, by product
6.3.4.4. France market size and forecast, by end user
6.3.4.5. UK market size and forecast, by end user
6.3.4.6. UK market size and forecast, by end user
6.3.4.7. Italy market size and forecast, by product
6.3.4.8. Italy market size and forecast, by end user
6.3.4.10. Rest of Europe market size and forecast, by product
6.3.4.11. Rest of Europe market size and forecast, by end user

6.4. Asia-Pacific

6.4.1. Key growth factors and opportunities.
6.4.2. Market size and forecast, by country
6.4.3. Market size and forecast, by product
6.4.4. Market size and forecast, by end user

6.4.4.1. Japan market size and forecast, by end user
6.4.4.2. Japan market size and forecast, by end user
6.4.4.3. China market size and forecast, by product
6.4.4.4. China market size and forecast, by end user
6.4.4.5. India market size and forecast, by product
6.4.4.6. India market size and forecast, by end user
6.4.4.7. Rest of Asia-Pacific market size and forecast, by product
6.4.4.8. Rest of Asia-Pacific market size and forecast, by end user

6.5. LAMEA

6.5.1. Key growth factors and opportunities
6.5.2. Market size and forecast, by country
6.5.3. Market size and forecast, by product
6.5.4. Market size and forecast, by end user

6.5.4.1. Brazil market size and forecast, by end user
6.5.4.2. Brazil market size and forecast, by end user
6.5.4.3. Saudi Arabia market size and forecast, by product
6.5.4.4. Saudi Arabia market size and forecast, by end user
6.5.5.1. South Africa market size and forecast, by product
6.5.5.2. South Africa market size and forecast, by end user
6.5.5.3. Rest of LAMEA market size and forecast, by product
6.5.5.4. Rest of LAMEA market size and forecast, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Abbott Laboratories

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance

7.2. B. BRAUN MELSUNGEN AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance

7.3. Boston Scientific Corporation

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Integra LifeSciences Holdings Corporation

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. Johnson & Johnson

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance

7.6. LivaNova PLC

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. Medtronic Plc

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Magstim Co Ltd.

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Product portfolio
7.8.4. Key strategic moves and developments

7.9. Penumbra, Inc.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance

7.10. Stryker Corporation

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance

LIST OF TABLES

TABLE 01. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. NEUROSTIMULATION DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 03. NEUROSURGERY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 04. INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 05. CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 06. OTHER DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 07. NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION, 2018–2026 ($MILLION)
TABLE 09. NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2018–2026 ($MILLION)
TABLE 10. NEUROLOGY DEVICES MARKET FOR NEUROLOGY CLINICS, BY REGION, 2018–2026 ($MILLION)
TABLE 11. GLOBAL NEUROLOGY DEVICES MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 13. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 14. NORTH AMERICA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),
TABLE 15. U.S. NEUROLOGY DEVICES MARKET BY PRODUCT, 2018–2026 ($MILLION)
TABLE 16. U.S. NEUROLOGY DEVICES MARKET BY END USER, 2018–2026 ($MILLION)
TABLE 17. CANADA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18. CANADA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. MEXICO NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 20. MEXICO NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. EUROPE NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 22. EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 23. EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),
TABLE 24. GERMANY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 25. GERMANY NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. FRANCE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 27. FRANCE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. U.K. NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 29. U.K. NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. ITALY NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31. ITALY NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 33. REST OF EUROPE NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),
TABLE 37. JAPAN NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 38. JAPAN NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. CHINA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40. CHINA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. INDIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 42. INDIA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 44. REST OF ASIA-PACIFIC NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. LAMEA NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 47. LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION),
TABLE 48. BRAZIL NEUROLOGY DEVICES MARKET, BY PRODUCT 2018–2026 ($MILLION)
TABLE 49. BRAZIL NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 50. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 51. SAUDI ARABIA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 52. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53. SOUTH AFRICA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 54. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 55. REST OF LAMEA NEUROLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. ABBOTT: COMPANY SNAPSHOT
TABLE 57. ABBOTT: OPERATING SEGMENTS
TABLE 58. ABBOTT: PRODUCT PORTFOLIO
TABLE 59. B. BRAUN: COMPANY SNAPSHOT
TABLE 60. B. BRAUN: OPERATING SEGMENTS
TABLE 61. B. BRAUN: PRODUCT PORTFOLIO
TABLE 62. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 63. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 64. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 65. INTEGRA: COMPANY SNAPSHOT
TABLE 66. INTEGRA: OPERATING SEGMENTS
TABLE 67. INTEGRA: PRODUCT PORTFOLIO
TABLE 68. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 69. J&J: OPERATING SEGMENT
TABLE 70. J&J.: PRODUCT PORTFOLIO
TABLE 71. LIVANOVA: COMPANY SNAPSHOT
TABLE 72. LIVANOVA: OPERATING SEGMENT
TABLE 73. LIVANOVA: PRODUCT PORTFOLIO
TABLE 74. MEDTRONIC: COMPANY SNAPSHOT
TABLE 75. MEDTRONIC: OPERATING SEGMENTS
TABLE 76. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 77. MAGSTIM: OPERATING SEGMENT
TABLE 78. MAGSTIM: PRODUCT PORTFOLIO
TABLE 79. PENUMBRA.: COMPANY SNAPSHOT
TABLE 80. PENUMBRA.: OPERATING SEGMENTS
TABLE 81. PENUMBRA.: PRODUCT PORTFOLIO
TABLE 82. STRYKER: COMPANY SNAPSHOT
TABLE 83. STRYKER: OPERATING SEGMENTS
TABLE 84. STRYKER: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. GLOBAL NEUROLOGY DEVICES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING
FIGURE 04. GLOBAL NEUROLOGY DEVICES MARKET: DRIVERS, RESTRAINT, AND OPPORTUNITY
FIGURE 05. COMPARATIVE SHARE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 06. COMPARATIVE SHARE ANALYSIS OF NEUROSURGERY DEVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 07. COMPARATIVE SHARE ANALYSIS OF INTERVENTIONAL NEUROLOGY DEVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF CEREBROSPINAL FLUID MANAGEMENT DEVICES MARKET, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF OTHER DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEUROLOGY DEVICES MARKET FOR NEUROLOGY CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 14. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 15. ABBOTT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 16. NET SALES, 2016–2018 ($MILLION)
FIGURE 17. B. BRAUN: NET SALES BY DIVISION, 2018 (%)
FIGURE 18. B. BRAUN: NET SALES BY REGION, 2018 (%)
FIGURE 19. BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 22. INTEGRA: REVENUE, 2016–2018 ($MILLION)
FIGURE 23. INTEGRA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. INTEGRA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. J&J: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. J&J: REVENUE SHARE BY SEGMENTATION, 2016-2018(%)
FIGURE 27. J&J: REVENUE SHARE BY REGION, 2016-2018(%)
FIGURE 28. LIVANOVA: REVENUE, 2016–2018 ($MILLION)
FIGURE 29. LIVANOVA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. LIVANOVA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. PENUMBRA: NET SALES, 2016-2018($MILLION)
FIGURE 01. PENUMBRA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 02. PENUMBRA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 03. NET SALES, 2016–2018 ($MILLION)
FIGURE 04. STRYKER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 05. STRYKER: REVENUE SHARE BY REGION, 2018 (%)

 
 

Neurological devices are widely being used for diagnosis and treatment of various neurological disorders such as Alzheimer’s, Parkinson’s disease, tumors, and stroke. Furthermore, significant improvements have been made in the management of neurological conditions such as stroke, epilepsy, and others. In addition, introduction of technologically advanced devices has helped in understanding the pathogenesis of neurodegenerative diseases, and further has enabled the treatment of conditions such as motor neuron disease and Alzheimer's disease. The application of the techniques of molecular genetics and molecular cell biology has advanced the understanding and diagnosis of several neurological disorders, such as Huntington's disease and myotonic dystrophy. Current areas of neurological research include the latent use of stem cells to treat several neurological disorders.

The global neurological devices market is anticipated to witness a steady growth in the future, owing to rise in prevalence of neurological disorders across the globe. Furthermore, surge in development of neurological devices such as neurostimulation devices and interventional neurology devices propels the market growth. However, dearth of skilled labors and high cost of the treatment & diagnosis of neurological disorders are expected to hamper the market growth in the future. Conversely, continuous focus of researchers toward the development of innovative devices is anticipated to create lucrative opportunities for market expansion in the near future.

 

PURCHASE OPTIONS

Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, Subscription @ $699 T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
 

A. The market vaule of global neurology devices market was $9,242 million in 2018.

A. The forecast period is from 2019 to 2026.

A. The market value of global neurology devices market in 2019 is $10,065 million.

A. The market is anticipated to propel in the near future owing to the increase in neurovascular disorders across the globe.

A. No, the report does not provides value chain analysis.

A. Introduction of minimally invasive neurology devicess.

A. Emerging countries of Asia-Pacific region are growing at a growth rate of 9.6%. India, China, Australia, are expected grow at a CAGR of 11.8%, 10.1%, 10.3%% respectively.

A. The North America market held a major share in the neurology devices market in 2018 and is expected to continue the trend in the forecasting period. This is attributed to increase in neurological diseases such as Alzeimers, strokes and others in this region.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Neurology devices Market

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $0.00
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts